Author

Ellina Ruzanova

Observed names: E. Ruzanova, E.A. Ruzanova, EA Ruzanova, Ellina A. Ruzanova

Institutions: State Research Institute of Highly Pure Biopreparations, Federal Medical-Biological Agency

Observed institutions: State Research Institute of Highly Pure Biopreparations, Federal Medical-Biological Agency

ORCID: 0000-0002-7965-663X

Observed ORCID: 0000-0002-7965-663X

OpenAlex ID: A5049989654

Treatment of COVID ‐19 patients with a SARS‐CoV ‐2‐specific siRNA ‐peptide dendrimer formulation

2023 · Musa Khaitov, Alexandra Nikonova, et al. · Allergy · 41

Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®

2023 · Sevastyan O. Rabdano, Ellina Ruzanova, et al. · Vaccines · 20

N-protein vaccine is effective against COVID-19: Phase 3, randomized, double-blind, placebo-controlled clinical trial

2024 · Sevastyan O. Rabdano, Ellina A. Ruzanova, et al. · Journal of Infection · 19

N protein based vaccine against SARS-CoV-2 produces a strong T cell immune response to N Protein of novel strains

2022 · SO Rabdano, VE Mukhin, et al. · Medicine of Extreme Situations · 7

Phase 2‐3 Trial: Prevention of the Progression to Moderate and Severe COVID ‐19 in SARS ‐ CoV ‐2‐Infected Non‐Hospitalized Adults With Inhaled siRNA ‐Based MIR 19

2025 · M. Khaitov, A. Nikonova, et al. · Allergy · 6

Results of clinical trials phases I and II of MIR 19®

2023 · M.R. Khaitov, A.A. Nikonova, et al. · Immunologiya · 6

Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine

2024 · Sevastyan Rabdano, Ellina Ruzanova, et al. · Vaccines · 4

Regenerative therapy by tissue-protective cytokines as a component of bacterial cellulose based wound dressings

2016 · Н. Г. Венгерович, А. К. Хрипунов, et al. · Research Repository Saint Petersburg State University (Saint Petersburg State University) · 1

Works count: 8

Citation count: 104

H-index: 6

I10-index: 3